Title: An open label, 3-arm, randomised phase 2 study to compare the safety and efficacy of ponatinib in combination with either chemotherapy or blinatumomab

Funder
Amgen Ltd

Principal Investigator

Ottmann, Oliver


Co-Investigators
Thomas, Ian


Project Details

Net value award figure for Cardiff University: £357,047.43

Start date: 01/01/2019

End date: 30/06/2024


Last updated on 2024-24-03 at 04:46